Imperial Capital Upgrades Tenet Healthcare (THC) to Outperform
Tweet Send to a FriendGet Alerts THC Hot Sheet
Price: $44.11 -3.75%
Rating Summary:
14 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Rating Summary:
14 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Trade THC Now!
Earlier, Imperial Capital upgraded Tenet Healthcare (NYSE: THC) from In-Line to Outperform with a price target of $40.00 (from $20.00).
The firm comments, "In our view, several key electoral victories broke in Tenet’s favor (Presidential, Senate, California Proposition 30), guidance for 2013 EBITDA is achievable, and significantly improved multi-year visibility warrants a higher target multiple (increased to 6.5x from an historical low of 5.0x, more consistent with the industry level). We believe that Tenet has crossed a bridge to greater multi-year visibility on its operations by demonstrating the earnings benefits of its operational programs (MPI, outpatient acquisitions, Conifer, etc.), thwarting a hostile bid for the company during a transition phase, and soon benefitting from a multi-year tailwind for the industry. Additionally, we believe that the company may be taking a more conservative stance on earnings guidance. We now have Outperform ratings on all seven publicly traded hospital operators, owing largely to our expectation for margin expansion in 2014 and sustained, incremental Affordable Care Act (ACA)-driven growth in the successive years."
For an analyst ratings summary and ratings history on Tenet Healthcare click here. For more ratings news on Tenet Healthcare click here.
Shares of Tenet Healthcare closed at $33.39 yesterday, with a 52 week range of $4.31-$33.86.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The firm comments, "In our view, several key electoral victories broke in Tenet’s favor (Presidential, Senate, California Proposition 30), guidance for 2013 EBITDA is achievable, and significantly improved multi-year visibility warrants a higher target multiple (increased to 6.5x from an historical low of 5.0x, more consistent with the industry level). We believe that Tenet has crossed a bridge to greater multi-year visibility on its operations by demonstrating the earnings benefits of its operational programs (MPI, outpatient acquisitions, Conifer, etc.), thwarting a hostile bid for the company during a transition phase, and soon benefitting from a multi-year tailwind for the industry. Additionally, we believe that the company may be taking a more conservative stance on earnings guidance. We now have Outperform ratings on all seven publicly traded hospital operators, owing largely to our expectation for margin expansion in 2014 and sustained, incremental Affordable Care Act (ACA)-driven growth in the successive years."
For an analyst ratings summary and ratings history on Tenet Healthcare click here. For more ratings news on Tenet Healthcare click here.
Shares of Tenet Healthcare closed at $33.39 yesterday, with a 52 week range of $4.31-$33.86.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: BofA/Merrill Lynch Upgrades Adobe (ADBE) to Buy
- Lazard Raises PT on Chicago Bridge & Iron (CBI) to $75
- Deutsche Bank Sees Upside in AIG (AIG) Stock
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
